Hypertension Diagnostics(HDII)
$0.000.00 (0.00%)
HDII
Hypertension Diagnostics financials statements
$0.00
At close:0.00 (0.00%)
Hypertension Diagnostics (HDII) Ratios
17 Followers
Hypertension Diagnostics Ratios
HDII's free cash flow for Q2 2021 was $-11.00K. For the 2021 fiscal year, HDII's free cash flow was increased by $0.00 and operating cash flow was $-11.00K. See a summary of the company’s cash flow.
| Ratios | Dec 21 | Dec 20 | Dec 19 | Dec 18 | Dec 17 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.00 | 0.38 | 0.38 | 0.53 | 0.52 |
| Quick Ratio | 0.00 | 0.24 | 0.24 | 0.38 | 0.41 |
| Cash Ratio | 0.00 | 0.06 | 0.06 | 0.06 | 0.17 |
| Solvency Ratio | 1.11 | 0.11 | 1.65 | -0.01 | -0.06 |
| Operating Cash Flow Ratio | -7.32 | -0.01 | 2.60 | -0.29 | -0.05 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -121.89K | $ -1.49M | $ -1.61M | $ -5.32M | $ -5.23M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.60 | 0.72 | 3.67 | 2.97 |
| Debt-to-Equity Ratio | 0.00 | -0.71 | -0.75 | -0.99 | -0.95 |
| Debt-to-Capital Ratio | 0.00 | -2.48 | -2.95 | -70.66 | -21.17 |
| Long-Term Debt-to-Capital Ratio | 0.00 | -2.48 | -2.95 | -70.66 | -21.17 |
| Financial Leverage Ratio | 0.00 | -1.18 | -1.04 | -0.27 | -0.32 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.45 | -1.13 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | -1.00 | -2.54 |
| Debt to Market Cap | 0.00 | 0.25 | 0.36 | 26.34 | 23.66 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.01 | 0.04 | 0.05 |
| Net Debt to EBITDA | 0.00 | 2.50 | 0.20 | 63.62 | -23.09 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 25.17% | 20.46% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.02% | -5.71% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 1.91% | -4.87% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | -4.25% | -10.96% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | -3.30% | -10.03% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | -3.30% | -10.03% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | -3.30% | -10.03% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 76.50% | 100.00% | -784.29% | 77.64% | 91.56% |
| Return on Assets (ROA) | 0.00% | -1.02% | 304.51% | -9.78% | -24.78% |
| Return on Equity (ROE) | 76.50% | 1.20% | -317.53% | 2.63% | 7.98% |
| Return on Capital Employed (ROCE) | 100.00% | 4.19% | 160.07% | 242.81% | 202.86% |
| Return on Invested Capital (ROIC) | 100.00% | 4.19% | 160.07% | 242.81% | 202.86% |
| Return on Tangible Assets | 0.00% | -1.02% | 304.51% | -9.78% | -24.78% |
| Earnings Yield | -5.72% | -0.42% | 153.06% | -70.28% | -197.65% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 9.77 | 9.91 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 6.37 | 6.93 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 14.98 | 15.68 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 7.44 | 6.74 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 2.97 | 2.47 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | -5.26 | -4.91 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 4.40 | 7.43 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 37.35 | 36.84 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 24.36 | 23.27 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 57.32 | 52.68 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 61.71 | 60.11 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.00 | 0.03 | -0.00 | -0.00 |
| Free Cash Flow Per Share | -0.00 | -0.00 | 0.03 | -0.00 | -0.00 |
| Dividend Paid and CapEx Coverage Ratio | -297419.00 | 0.00 | 0.00 | -184.40 | -42.26 |
| Capital Expenditure Coverage Ratio | -297419.00 | 0.00 | 0.00 | -184.40 | -42.26 |
| Operating Cash Flow Coverage Ratio | 0.00 | -0.02 | 4.50 | -0.08 | -0.02 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | -0.10 | -0.02 |
| Free Cash Flow Yield | -54.74% | -0.42% | 162.19% | -220.06% | -47.11% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -17.48 | -237.34 | 0.65 | -1.42 | -0.51 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.05 | 0.05 |
| Price-to-Book (P/B) Ratio | -13.37 | -2.86 | -2.07 | -0.04 | -0.04 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.83 | -237.34 | 0.62 | -0.45 | -2.12 |
| Price-to-Operating Cash Flow Ratio | -1.83 | -237.34 | 0.62 | -0.46 | -2.17 |
| Price-to-Earnings Growth (PEG) Ratio | -0.06 | 2.36 | -0.00 | 0.02 | 0.01 |
| Enterprise Value Multiple | 12.05 | 14.08 | 0.81 | 66.08 | -24.13 |
| Enterprise Value | 1.63M | 3.18M | 2.84M | 4.78M | 4.32M |
| EV to EBITDA | 12.05 | 14.08 | 0.81 | 66.08 | -24.13 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 1.26 | 1.17 |
| EV to Free Cash Flow | -1.83 | -288.69 | 0.81 | -12.21 | -49.11 |
| EV to Operating Cash Flow | -1.83 | -288.69 | 0.81 | -12.27 | -50.27 |
| Tangible Book Value Per Share | -0.00 | -0.01 | -0.01 | -0.03 | -0.05 |
| Shareholders’ Equity Per Share | -0.00 | -0.01 | -0.01 | -0.03 | -0.05 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.03 | 0.04 |
| Net Income Per Share | -0.00 | -0.00 | 0.02 | -0.00 | -0.00 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | -177.05 | 1.76 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 9.57 | 1.00 | 1.06 | 3.10 | 0.23 |
Currency in USD

